Literature DB >> 9512402

Post-ischemic changes in the expression of Alzheimer's APP isoforms in rat cerebral cortex.

H S Kim1, S H Lee, S S Kim, Y K Kim, S J Jeong, J Ma, D H Han, B K Cho, Y H Suh.   

Abstract

A significant porportion (25%) of patients with Alzheimer's disease (AD) also shows vascular pathology. Recent ultrastructural studies demonstrated characteristic and extensive angio-architectural distortions of cerebral capillaries in AD brains. We examined the expression of APP mRNA isoforms of cerebral cortex after transient ischemia by middle cerebral artery occlusion, using RT-PCR. Neuronal damage and glial fibrillary acidic protein immunohistochemistry were also examined histologically. After transient ischemia, the Kunitz protease inhibitor-bearing isoforms (KPI-APP) were increased whereas APP 695, which lacks KPI domain, was decreased. Neuronal damage and GFAP-immunoreactive astrocytes were also observed. These results show that focal, transient ischemia alters KPI-APP/APP 695 ratio in cerebral cortex and this shift in APP isoforms could be related to neurodegeneration and/or activation of astrocytes during the ischemic process.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9512402

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  10 in total

1.  Links between the pathology of Alzheimer's disease and vascular dementia.

Authors:  Marcin Sadowski; Joanna Pankiewicz; Henrieta Scholtzova; Yong-sheng Li; David Quartermain; Karen Duff; Thomas Wisniewski
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

2.  Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI.

Authors:  Chandan Misra; Yong Fan; Christos Davatzikos
Journal:  Neuroimage       Date:  2008-11-05       Impact factor: 6.556

Review 3.  Traumatic brain injury: cause or risk of Alzheimer's disease? A review of experimental studies.

Authors:  J Szczygielski; A Mautes; W I Steudel; P Falkai; T A Bayer; O Wirths
Journal:  J Neural Transm (Vienna)       Date:  2005-06-15       Impact factor: 3.575

4.  Activation of extrasynaptic, but not synaptic, NMDA receptors modifies amyloid precursor protein expression pattern and increases amyloid-ß production.

Authors:  Karim Bordji; Javier Becerril-Ortega; Olivier Nicole; Alain Buisson
Journal:  J Neurosci       Date:  2010-11-24       Impact factor: 6.167

5.  Environmental experience modulates ischemia-induced amyloidogenesis and enhances functional recovery.

Authors:  Teresita L Briones; Magdalena Rogozinska; Julie Woods
Journal:  J Neurotrauma       Date:  2009-04       Impact factor: 5.269

6.  The non-peptidic δ-opioid receptor agonist Tan-67 mediates neuroprotection post-ischemically and is associated with altered amyloid precursor protein expression, maturation and processing in mice.

Authors:  Jia-Wei Min; Yanying Liu; David Wang; Fangfang Qiao; Hongmin Wang
Journal:  J Neurochem       Date:  2017-12-19       Impact factor: 5.372

7.  Spatial patterns of brain atrophy in MCI patients, identified via high-dimensional pattern classification, predict subsequent cognitive decline.

Authors:  Yong Fan; Nematollah Batmanghelich; Chris M Clark; Christos Davatzikos
Journal:  Neuroimage       Date:  2007-11-01       Impact factor: 6.556

Review 8.  Brain ischemia activates β- and γ-secretase cleavage of amyloid precursor protein: significance in sporadic Alzheimer's disease.

Authors:  Ryszard Pluta; Wanda Furmaga-Jabłońska; Ryszard Maciejewski; Marzena Ułamek-Kozioł; Mirosław Jabłoński
Journal:  Mol Neurobiol       Date:  2012-10-19       Impact factor: 5.590

Review 9.  Sporadic Alzheimer's disease begins as episodes of brain ischemia and ischemically dysregulated Alzheimer's disease genes.

Authors:  Ryszard Pluta; Mirosław Jabłoński; Marzena Ułamek-Kozioł; Janusz Kocki; Judyta Brzozowska; Sławomir Januszewski; Wanda Furmaga-Jabłońska; Anna Bogucka-Kocka; Ryszard Maciejewski; Stanisław J Czuczwar
Journal:  Mol Neurobiol       Date:  2013-03-22       Impact factor: 5.590

Review 10.  Shared Genomic and Proteomic Contribution of Amyloid and Tau Protein Characteristic of Alzheimer's Disease to Brain Ischemia.

Authors:  Ryszard Pluta; Marzena Ułamek-Kozioł; Sławomir Januszewski; Stanisław J Czuczwar
Journal:  Int J Mol Sci       Date:  2020-04-30       Impact factor: 6.208

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.